Literature DB >> 23175288

Absolute lymphocyte count predicts the response to new influenza virus H1N1 vaccination in pediatric cancer patients.

Annelies M C Mavinkurve-Groothuis1, Michiel van der Flier, Foekje Stelma, Coretta van Leer-Buter, Frank W Preijers, Peter M Hoogerbrugge.   

Abstract

We measured the vaccination response to the new H1N1 virus in relation to the lymphocyte count prior to vaccination in pediatric cancer patients. The absolute lymphocyte count above the lower normal limits (LNL) for age prior to vaccination predicts the response to influenza vaccination in pediatric cancer patients treated with chemotherapy.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23175288      PMCID： PMC3535770          DOI： 10.1128/CVI.00585-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  14 in total

1.  Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels.

Authors:  Grazia Galli; Duccio Medini; Erica Borgogni; Luisanna Zedda; Monia Bardelli; Carmine Malzone; Sandra Nuti; Simona Tavarini; Chiara Sammicheli; Anne K Hilbert; Volker Brauer; Angelika Banzhoff; Rino Rappuoli; Giuseppe Del Giudice; Flora Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 2.  Update on the 2009 pandemic influenza A H1N1 in children.

Authors:  Natasha B Halasa
Journal:  Curr Opin Pediatr       Date:  2010-02       Impact factor: 2.856

3.  Successful H1N1 influenza vaccination of children receiving chemotherapy for solid tumors.

Authors:  Kayss Shahin; Bruno Lina; Genevieve Billaud; Claire Pedone; Cecile Faure-Conter
Journal:  J Pediatr Hematol Oncol       Date:  2012-08       Impact factor: 1.289

Review 4.  Utility of influenza vaccination for oncology patients.

Authors:  Daniel A Pollyea; Janice M Y Brown; Sandra J Horning
Journal:  J Clin Oncol       Date:  2010-04-12       Impact factor: 44.544

5.  Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

Authors:  Terry Nolan; Jodie McVernon; Maryanne Skeljo; Peter Richmond; Ushma Wadia; Stephen Lambert; Michael Nissen; Helen Marshall; Robert Booy; Leon Heron; Gunter Hartel; Michael Lai; Russell Basser; Charmaine Gittleson; Michael Greenberg
Journal:  JAMA       Date:  2009-12-21       Impact factor: 56.272

6.  Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients.

Authors:  Hikaru Yamanaka; Katsuji Teruya; Mari Tanaka; Yoshimi Kikuchi; Takao Takahashi; Satoshi Kimura; Shinichi Oka
Journal:  J Acquir Immune Defic Syndr       Date:  2005-06-01       Impact factor: 3.731

7.  Response to influenza immunisation during treatment for cancer.

Authors:  J C Chisholm; T Devine; A Charlett; C R Pinkerton; M Zambon
Journal:  Arch Dis Child       Date:  2001-06       Impact factor: 3.791

8.  Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations.

Authors:  W M Comans-Bitter; R de Groot; R van den Beemd; H J Neijens; W C Hop; K Groeneveld; H Hooijkaas; J J van Dongen
Journal:  J Pediatr       Date:  1997-03       Impact factor: 4.406

9.  Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2009-08-28

Review 10.  Influenza vaccination in children being treated with chemotherapy for cancer.

Authors:  Ginette M Goossen; Leontien Cm Kremer; Marianne D van de Wetering
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15
View more
  5 in total

Review 1.  Guidelines on vaccinations in paediatric haematology and oncology patients.

Authors:  Simone Cesaro; Mareva Giacchino; Francesca Fioredda; Angelica Barone; Laura Battisti; Stefania Bezzio; Stefano Frenos; Raffaella De Santis; Susanna Livadiotti; Serena Marinello; Andrea Giulio Zanazzo; Désirée Caselli
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

2.  Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects.

Authors:  Jiaqi Zhang; Shan Xing; Dan Liang; Wei Hu; Changwen Ke; Jinyong He; Runyu Yuan; Yile Huang; Yizhe Li; Dongdong Liu; Xuedong Zhang; Lin Li; Jianhua Lin; Weili Li; Xiangyun Teng; Yijun Liu; Wei Wen; Qiang Kang; Dawei Wang; Wanli Liu; Jianhua Xu
Journal:  Front Cell Infect Microbiol       Date:  2021-12-16       Impact factor: 5.293

3.  Antibody response to the messenger RNA-1273 vaccine (Moderna) in liver transplant recipients.

Authors:  Antonio Cuadrado; María Del Barrio; José Ignacio Fortea; Lidia Amigo; David San Segundo; María Paz Rodriguez-Cundin; María Henar Rebollo; Roberto Fernandez-Santiago; Federico Castillo; Maria Achalandabaso; Juan Echeverri; Edward J Anderson; Juan Carlos Rodríguez-Sanjuan; Marcos López-Hoyos; Javier Crespo; Emilio Fábrega
Journal:  Hepatol Commun       Date:  2022-03-28

4.  Absolute Lymphocyte Count After COVID-19 Vaccination Is Associated with Vaccine-Induced Hypermetabolic Lymph Nodes on 18F-FDG PET/CT: A Focus in Breast Cancer Care.

Authors:  Romain-David Seban; Capucine Richard; Camila Nascimento-Leite; Jerome Ghidaglia; Claire Provost; Julie Gonin; Christophe Le Tourneau; Emanuela Romano; Nicolas Deleval; Laurence Champion
Journal:  J Nucl Med       Date:  2021-12-02       Impact factor: 11.082

5.  Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy.

Authors:  Evelin A Leibinger; Gábor Pauler; Noémi Benedek; Tímea Berki; István Jankovics; Richard McNally; Gábor Ottóffy
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.